Spain · Delayed Price · Currency is EUR CLERHP Estructuras Statistics
Total Valuation
BME:CLR has a market cap or net worth of EUR 188.75 million. The enterprise value is 202.01 million.
| Market Cap | 188.75M |
| Enterprise Value | 202.01M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:CLR has 17.81 million shares outstanding. The number of shares has decreased by -0.40% in one year.
| Current Share Class | 17.81M |
| Shares Outstanding | 17.81M |
| Shares Change (YoY) | -0.40% |
| Shares Change (QoQ) | -0.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.51% |
| Float | 9.86M |
Valuation Ratios
The trailing PE ratio is 2,994.39 and the forward PE ratio is 265.00.
| PE Ratio | 2,994.39 |
| Forward PE | 265.00 |
| PS Ratio | 12.09 |
| PB Ratio | 24.39 |
| P/TBV Ratio | 24.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.26, with an EV/FCF ratio of -41.34.
| EV / Earnings | 3,204.75 |
| EV / Sales | 12.94 |
| EV / EBITDA | 35.26 |
| EV / EBIT | 40.93 |
| EV / FCF | -41.34 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.93.
| Current Ratio | 1.12 |
| Quick Ratio | 0.31 |
| Debt / Equity | 1.93 |
| Debt / EBITDA | 2.61 |
| Debt / FCF | -3.06 |
| Interest Coverage | 2.14 |
Financial Efficiency
Return on equity (ROE) is -4.28% and return on invested capital (ROIC) is 23.60%.
| Return on Equity (ROE) | -4.28% |
| Return on Assets (ROA) | 4.53% |
| Return on Invested Capital (ROIC) | 23.60% |
| Return on Capital Employed (ROCE) | 32.10% |
| Weighted Average Cost of Capital (WACC) | 10.48% |
| Revenue Per Employee | 171,566 |
| Profits Per Employee | 693 |
| Employee Count | 91 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 0.05 |
Taxes
In the past 12 months, BME:CLR has paid 345,131 in taxes.
| Income Tax | 345,131 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +203.73% in the last 52 weeks. The beta is 1.11, so BME:CLR's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +203.73% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 70.30 |
| Average Volume (20 Days) | 35,624 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CLR had revenue of EUR 15.61 million and earned 63,036 in profits. Earnings per share was 0.00.
| Revenue | 15.61M |
| Gross Profit | 13.42M |
| Operating Income | 4.94M |
| Pretax Income | -15,082 |
| Net Income | 63,036 |
| EBITDA | 5.73M |
| EBIT | 4.94M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1.80 million in cash and 14.97 million in debt, with a net cash position of -13.18 million or -0.74 per share.
| Cash & Cash Equivalents | 1.80M |
| Total Debt | 14.97M |
| Net Cash | -13.18M |
| Net Cash Per Share | -0.74 |
| Equity (Book Value) | 7.74M |
| Book Value Per Share | 0.53 |
| Working Capital | 8.23M |
Cash Flow
In the last 12 months, operating cash flow was -3.36 million and capital expenditures -1.53 million, giving a free cash flow of -4.89 million.
| Operating Cash Flow | -3.36M |
| Capital Expenditures | -1.53M |
| Depreciation & Amortization | 794,234 |
| Net Borrowing | 6.92M |
| Free Cash Flow | -4.89M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 85.98%, with operating and profit margins of 31.61% and 0.40%.
| Gross Margin | 85.98% |
| Operating Margin | 31.61% |
| Pretax Margin | -0.10% |
| Profit Margin | 0.40% |
| EBITDA Margin | 36.70% |
| EBIT Margin | 31.61% |
| FCF Margin | n/a |
Dividends & Yields
BME:CLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.40% |
| Shareholder Yield | 0.40% |
| Earnings Yield | 0.03% |
| FCF Yield | -2.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:CLR is 10.30, which is -2.83% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 10.30 |
| Price Target Difference | -2.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 159.49% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CLR has an Altman Z-Score of 0.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 3 |